Hydroxytyrosol Bioavailability: Unraveling Influencing Factors and Optimization Strategies for Dietary Supplements
Nutrients · 2025
DOI: 10.3390/nu17182937 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Marta Jordán und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Nutrition (DMN), Institute of Food Science Technology and Nutrition (ICTAN), Spanish National Research Council (CSIC), C…. Hauptthemen laut MEDLINE: Phenylethyl Alcohol, Dietary Supplements, Antioxidants. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades (MICIN) (Spain).
Abstract (Originalsprache)
Hydroxytyrosol (HT) is a major phenolic compound in olives and extra virgin olive oil (EVOO), known for its antioxidant, anti-inflammatory, and cardiometabolic properties. The European Food Safety Authority (EFSA) has approved a health claim for the protection of LDL particles from oxidative damage only when HT is consumed within EVOO, which limits its direct use in supplements or functional foods. Since its biological effects depend on absorption, distribution, metabolism, and excretion (ADME), understanding how formulation and delivery strategies influence bioavailability is essential. HT is mainly present as secoiridoid derivatives in EVOO, whereas in supplements, it often appears in its free form, potentially affecting its metabolic fate. This review summarizes human studies on HT bioavailability from EVOO, isolated supplements, and enriched foods, and examines how matrix type, chemical modifications of HT, and advanced delivery systems, such as emulsions, encapsulation, and vesicular carriers, modulate absorption and metabolism. The gut microbiota is highlighted as an emerging factor in HT biotransformation, although its role remains underexplored. Further well-designed human studies are needed to guide the development of nutraceutical formulations capable of replicating the health benefits of EVOO beyond its natural matrix.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Metabolism and Nutrition (DMN), Institute of Food Science Technology and Nutrition (ICTAN), Spanish National Research Council (CSIC), C/José Antonio Novais 6, 28040 Madrid, Spain.
- Department of Biochemistry and Molecular Biology, Faculty of Chemistry, Complutense University of Madrid, 28040 Madrid, Spain.
- Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.
- Department of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy, University of Seville, 41012 Sevilla, Spain.
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
ORCID-Profile: Marta Jordán, Natalia García-Acosta, José Luis Espartero, Raquel Mateos
Förderung
- Ministerio de Ciencia, Innovación y Universidades (MICIN) (Spain)
Zitieren
APA
Jordán, M., García-Acosta, N., Espartero, J. L., Goya, L., & Mateos, R. (2025). Hydroxytyrosol Bioavailability: Unraveling Influencing Factors and Optimization Strategies for Dietary Supplements. Nutrients. https://doi.org/10.3390/nu17182937
Vancouver
Jordán M, García-Acosta N, Espartero JL, Goya L, Mateos R. Hydroxytyrosol Bioavailability: Unraveling Influencing Factors and Optimization Strategies for Dietary Supplements. Nutrients. 2025. doi:10.3390/nu17182937
BibTeX
@article{Jordn2025,
author = {Jordán, Marta and García-Acosta, Natalia and Espartero, José Luis and Goya, Luis and Mateos, Raquel},
title = {Hydroxytyrosol Bioavailability: Unraveling Influencing Factors and Optimization Strategies for Dietary Supplements},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17182937}
}
EUVIMED